A Case of Moderate Hidradenitis Suppurativa and Psoriasis Treated with Secukinumab

Hidradenitis suppurativa (HS) is a disorder of the apocrine gland causing a chronic, recurrent and painful inflammation. It is a disabilitating condition and, though many therapeutic options are available, the response is often ineffective in most cases and patients can present many recurrences with...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuseppe, Pistone, Nicola, Pardo, Valentina, Caputo, Elena, Castelli, Salvatrice, Curiale, Rosario, Gurreri, Rita, Bongiorno Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029963/
https://www.ncbi.nlm.nih.gov/pubmed/30065588
http://dx.doi.org/10.5021/ad.2018.30.4.462
Descripción
Sumario:Hidradenitis suppurativa (HS) is a disorder of the apocrine gland causing a chronic, recurrent and painful inflammation. It is a disabilitating condition and, though many therapeutic options are available, the response is often ineffective in most cases and patients can present many recurrences with physical and psychological sequelae. Recent data had shown increased interleukin (IL)-17 serum levels in patients with HS. Psoriasis is a chronic immune-mediated inflammatory disorder and new evidences have shown the role of Th17 cells in its pathogenesis and the therapeutic efficacy of anti-IL-17 antibodies. We present a case of a patient suffering from psoriasis and HS successfully treated with anti-IL-17 antibodies for both conditions. This is the first case report of HS treated with secukinumab.

Ejemplares similares